Kwon et al. reported that the allergic responses were improved when EC-SOD was administered to mice with allergic asthma.[11] In addition, severe allergic asthma was induced in EC-SOD knockout mice.[11] Taken together, these results suggest that increasing the expression of EC-SOD can be a good strategy for anti-allergic treatments. This evidence concerns the gene SOD1 and allergic asthma.